<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Up till now no standard therapy for <z:chebi fb="6" ids="22696">Beh</z:chebi>çet syndrome has existed </plain></SENT>
<SENT sid="1" pm="."><plain>Long-term corticoid therapy is often necessary, although side-effects cannot be avoided </plain></SENT>
<SENT sid="2" pm="."><plain>Recent investigations have shown a correlation between high endogenous gamma-interferon serum levels and low activity of the syndrome </plain></SENT>
<SENT sid="3" pm="."><plain>A 20-year-old male with severe <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's syndrome was therefore treated with recombinant alpha-A-interferon (IFN) </plain></SENT>
<SENT sid="4" pm="."><plain>The general condition of the patient improved rapidly, together with rapid clearing of the <z:mp ids='MP_0001212'>skin lesions</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Over a 10.5 week-period the patient received a total dose of 792 million IU recombinant alpha-A-interferon </plain></SENT>
</text></document>